Romanelli Joseph

Average Profitability
0.2%
Insider Buys Quantity
8
Insider Buys Sum
$44,336.21
Insider Sells Quantity
4
Insider Sells Sum
$679,207.17

Insider Activity of Romanelli Joseph

According to the SEC Form 4 filings, Romanelli Joseph, being in a position of

  1. President, Human Health Int?l at Merck & Co., Inc.,
    оver the last 12 months, has bought 0 shares, and sold 1000 shares for $124,888,
    over all time since 2022-12-02, has bought 409 shares for $44,336, and sold 6124 shares for $679,207.

The largest purchase of all time was on 2023-03-20 and amounted to 136 shares of Merck & Co., Inc. for $14,344.

The largest sale of all time was on 2023-02-15 and amounted to 5000 shares of Merck & Co., Inc. for $541,101.

Biography of Romanelli Joseph

No biography is available at this moment.

2024-02-13SaleMerck & Co., Inc.
MRK
President, Human Health Int?l
1,000
<0.0001%
$124.89$124,888-0.16%
2023-08-02SaleMerck & Co., Inc.
MRK
President, Human Health Int?l
89
<0.0001%
$107.37$9,556+12.37%
2023-04-26PurchaseMerck & Co., Inc.
MRK
President, Human Health Int?l
3
<0.0001%
$113.68$341-2.52%
2023-03-24SaleMerck & Co., Inc.
MRK
President, Human Health Int?l
35
<0.0001%
$104.65$3,663+4.95%
2023-03-20PurchaseMerck & Co., Inc.
MRK
President, Human Health Int?l
136
<0.0001%
$105.47$14,344+3.74%
2023-02-21PurchaseMerck & Co., Inc.
MRK
President, Human Health Int?l
11
<0.0001%
$109.20$1,201+0.77%
2023-02-15SaleMerck & Co., Inc.
MRK
President, Human Health Int?l
5,000
0.0002%
$108.22$541,101+1.79%
2022-12-19PurchaseMerck & Co., Inc.
MRK
President, Human Health Int?l
7
<0.0001%
$109.04$763-0.44%
2022-12-13PurchaseMerck & Co., Inc.
MRK
President, Human Health Int?l
56
<0.0001%
$110.96$6,214-0.91%
2022-12-06PurchaseMerck & Co., Inc.
MRK
President, Human Health Int?l
30
<0.0001%
$109.39$3,282+1%
2022-12-05PurchaseMerck & Co., Inc.
MRK
President, Human Health Int?l
107
<0.0001%
$109.54$11,721+<0.01%
2022-12-02PurchaseMerck & Co., Inc.
MRK
President, Human Health Int?l
59
<0.0001%
$109.67$6,471-0.02%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.